Innovation1 Biotech Inc.
IVBT
$0.00
$0.000.00%
OTC PK
| 02/29/2024 | 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1,753.45% | -88.35% | -35.07% | 46.10% | 364.60% |
| Total Receivables | -- | -- | -85.99% | 0.00% | 0.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.00% | -24.67% | -49.66% | -9.97% | -37.66% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 594.74% | -76.48% | -55.37% | 14.72% | 17.65% |
|
|
|||||
| Total Current Assets | 594.74% | -76.48% | -55.37% | 14.72% | 17.65% |
| Net Property, Plant & Equipment | -23.08% | -18.75% | -11.11% | -14.29% | -99.51% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | -99.95% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 0.00% | 0.00% |
| Total Assets | 504.48% | -73.55% | -98.03% | 0.54% | -9.65% |
|
|
|||||
| Total Accounts Payable | -0.76% | 2.29% | 14.19% | -3.74% | 55.63% |
| Total Accrued Expenses | 6.32% | -77.18% | 82.34% | -7.32% | 51.71% |
| Short-term Debt | 0.00% | 400.00% | 0.00% | 0.00% | 0.00% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 11.81% | 13.19% | 14.19% | 16.94% | 26.46% |
| Total Other Current Liabilities | 11.81% | 13.19% | 14.19% | 16.94% | 26.46% |
| Total Current Liabilities | 9.34% | -19.20% | 31.80% | 6.81% | 22.00% |
|
|
|||||
| Total Current Liabilities | 9.34% | -19.20% | 31.80% | 6.81% | 22.00% |
| Long-Term Debt | 33.89% | 89.32% | 97.65% | 394.64% | 729.63% |
| Short-term Debt | 0.00% | 400.00% | 0.00% | 0.00% | 0.00% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 12.66% | -12.43% | 34.60% | 10.50% | 9.04% |
|
|
|||||
| Common Stock & APIC | 0.42% | 1.44% | 0.00% | 0.54% | 15.71% |
| Retained Earnings | -0.89% | -0.71% | -8.68% | -0.97% | -17.76% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -9.39% | 11.04% | -376.41% | -15.41% | -29.15% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -9.39% | 11.04% | -376.41% | -15.41% | -29.15% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.41% | 11.07% | -374.01% | -15.33% | -29.03% |
|
|
|||||